Vesicare and Fanapt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vesicare and Fanapt. Common interactions include blood pressure decreased among females and dizziness among males.

The phase IV clinical study analyzes what interactions people who take Vesicare and Fanapt have. It is created by eHealthMe based on reports of 6 people who take Vesicare and Fanapt from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 30, 2022

6 people who take Vesicare and Fanapt together, and have interactions are studied.


What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 29,489 Vesicare users for its effectiveness, alternative drugs and more.

What is Fanapt?

Fanapt has active ingredients of iloperidone. It is often used in schizophrenia. eHealthMe is studying from 1,407 Fanapt users for its effectiveness, alternative drugs and more.

Number of Vesicare and Fanapt reports submitted per year:

Vesicare and Fanapt drug interactions.

Common Vesicare and Fanapt drug interactions by gender *:

female:

  1. Blood pressure decreased
  2. Chills
  3. Constipation
  4. Disturbance in attention
  5. Dizziness
  6. Drug effect decreased
  7. Dry mouth
  8. Dysphagia
  9. Dysphonia
  10. Dyspnoea

male:

  1. Dizziness
  2. Dysstasia
  3. Hypotension
  4. Sedation
  5. Abnormal behaviour
  6. Alcoholism
  7. Bladder disorder

Common Vesicare and Fanapt drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abnormal behaviour
  2. Alcoholism
  3. Bladder disorder

30-39:

n/a

40-49:

  1. Impaired gastric emptying
  2. Insomnia
  3. Loss of consciousness
  4. Mania
  5. Vision blurred
  6. Constipation
  7. Dry mouth
  8. Fatigue
  9. Feeling hot
  10. Frequent bowel movements

50-59:

n/a

60+:

  1. Dizziness
  2. Dysstasia
  3. Hypotension
  4. Sedation

* Approximation only. Some reports may have incomplete information.

Do you take Vesicare and Fanapt?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Vesicare and Fanapt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vesicare interactions:

Browse all interactions between Vesicare and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on solifenacin succinate and iloperidone (the active ingredients of Vesicare and Fanapt, respectively), and Vesicare and Fanapt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Vesicare and Fanapt.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: